Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells

更正：ATXN3 的下调增强了神经母细胞瘤细胞对 AKT 抑制剂（培利福辛或 MK-2206）的敏感性，但降低了其对化疗药物（依托泊苷或顺铂）的敏感性。